Aqr Capital Management LLC Neurocrine Biosciences Inc Transaction History

Aqr Capital Management LLC

  • $151 Billion
  • Q3 2025

A detailed history of Aqr Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 2,773,648 shares of NBIX stock, worth $402 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,773,648
Previous 1,510,015 83.68%
Holding current value
$402 Million
Previous $190 Million 105.15%
% of portfolio
0.26%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$123.98 - $146.67 $157 Million - $185 Million
1,263,633 Added 83.68%
2,773,648 $389 Million
Q2 2025

Aug 14, 2025
BUY
$87.54 - $128.18 $38.1 Million - $55.8 Million
435,385 Added 40.51%
1,510,015 $190 Million
Q1 2025

May 15, 2025
SELL
$107.22 - $153.29 $88.2 Million - $126 Million
-822,261 Reduced 43.35%
1,074,630 $119 Million
Q4 2024

Feb 14, 2025
BUY
$111.62 - $139.44 $5.98 Million - $7.48 Million
53,610 Added 2.91%
1,896,891 $259 Million
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $71.1 Million - $95 Million
620,226 Added 50.71%
1,843,281 $212 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $29.9 Million - $32.7 Million
228,444 Added 22.97%
1,223,055 $168 Million
Q1 2024

May 15, 2024
BUY
$130.4 - $143.74 $33.4 Million - $36.8 Million
255,759 Added 34.62%
994,611 $137 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $38.7 Million - $48.4 Million
364,890 Added 97.57%
738,852 $97.4 Million
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $1.53 Million - $1.9 Million
16,264 Added 4.55%
373,962 $42.1 Million
Q2 2023

Aug 14, 2023
BUY
$89.53 - $104.87 $11.3 Million - $13.3 Million
126,624 Added 54.8%
357,698 $33.7 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $11.7 Million - $15.3 Million
124,539 Added 116.9%
231,074 $23.4 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $754,296 - $898,060
-7,068 Reduced 6.22%
106,535 $12.7 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $7.51 Million - $8.8 Million
81,596 Added 254.93%
113,603 $11.9 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $3.09 Million - $4.08 Million
-40,742 Reduced 56.0%
32,007 $3.1 Million
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $2.01 Million - $2.63 Million
-27,772 Reduced 27.63%
72,749 $6.79 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $4.22 Million - $5.63 Million
52,958 Added 111.34%
100,521 $8.56 Million
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $607,741 - $698,359
7,052 Added 17.41%
47,563 $4.54 Million
Q2 2021

Aug 16, 2021
SELL
$89.43 - $102.27 $141,299 - $161,586
-1,580 Reduced 3.75%
40,511 $3.91 Million
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $2.69 Million - $3.67 Million
30,775 Added 271.96%
42,091 $4.09 Million
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $3.29 Million - $4.1 Million
-37,808 Reduced 76.96%
11,316 $1.06 Million
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $92,025 - $129,338
957 Added 1.99%
49,124 $4.72 Million
Q2 2020

Aug 17, 2020
BUY
$85.09 - $130.36 $1.2 Million - $1.84 Million
14,097 Added 41.38%
48,167 $5.88 Million
Q1 2020

May 15, 2020
BUY
$75.11 - $113.76 $698,673 - $1.06 Million
9,302 Added 37.56%
34,070 $2.95 Million
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $1.15 Million - $1.57 Million
13,257 Added 115.17%
24,768 $2.65 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $99,913 - $120,988
1,192 Added 11.55%
11,511 $1.03 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $3.71 Million - $4.68 Million
-51,329 Reduced 83.26%
10,319 $850,000
Q1 2019

May 14, 2019
SELL
$69.31 - $91.53 $4.01 Million - $5.3 Million
-57,876 Reduced 48.42%
61,648 $5.43 Million
Q4 2018

Feb 14, 2019
BUY
$68.32 - $124.36 $3.65 Million - $6.65 Million
53,487 Added 81.0%
119,524 $8.54 Million
Q3 2018

Nov 15, 2018
BUY
$98.88 - $125.85 $3.81 Million - $4.86 Million
38,582 Added 140.53%
66,037 $8.12 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $883,419 - $1.24 Million
11,732 Added 74.62%
27,455 $2.7 Million
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $1.19 Million - $1.45 Million
15,723 New
15,723 $1.3 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email